Omeros (OMER) Cash from Operations (2010 - 2026)
Omeros' (OMER) quarterly Cash from Operations came in at 14506000.0 in Q1 2026, up 59.53% year-on-year from 9093143.03 in Q1 2025, and up 63.59% quarter-over-quarter from 39842000.0 in Q4 2025.
Omeros (OMER) Cash from Operations (2010 - 2026) Analysis & Trends
Omeros has disclosed Cash from Operations across 17 years of filings, most recently posting 14506000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 14506000.0, up 59.53% year-over-year; the trailing twelve-month figure through Mar 2026 was 94759000.0 (up 33.67% YoY), and the FY2025 annual result was 116094000.0, up 21.98% from the prior year.
- Cash from Operations came in at 14506000.0 for Q1 2026 at Omeros, up from 39842000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 174539000.0 in Q1 2023 to a low of 45985000.0 in Q2 2024.
- The 5-year median for Cash from Operations is 28980000.0 (2024), against an average of 17127058.82.
- Across the five-year window, Cash from Operations jumped 1248.81% in 2023 and tumbled 123.94% in 2024, its largest moves.
- Omeros' Cash from Operations stood at 25382000.0 in 2022, then sank by 37.2% to 34825000.0 in 2023, then gained by 16.78% to 28980000.0 in 2024, then plunged by 37.48% to 39842000.0 in 2025, then soared by 63.59% to 14506000.0 in 2026.
- The last three Cash from Operations figures came in at 14506000.0 (Q1 2026), 39842000.0 (Q4 2025), and 18452000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | -14.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.51 Mn |
| Mar 31, 2026 | -14.51 Mn |
| Dec 31, 2025 | -39.84 Mn |
| Dec 31, 2025 | -39.84 Mn |
| Sep 30, 2025 | -18.45 Mn |
| Sep 30, 2025 | -18.45 Mn |
| Jun 30, 2025 | -21.96 Mn |
| Jun 30, 2025 | -21.96 Mn |
| Mar 31, 2025 | -35.84 Mn |
| Mar 31, 2025 | -35.84 Mn |
| Dec 31, 2024 | -28.98 Mn |
| Dec 31, 2024 | -28.98 Mn |
| Sep 30, 2024 | -32.06 Mn |
| Sep 30, 2024 | -32.06 Mn |
| Jun 30, 2024 | -45.99 Mn |
| Jun 30, 2024 | -45.99 Mn |
| Mar 31, 2024 | -41.78 Mn |
| Mar 31, 2024 | -41.78 Mn |
| Dec 31, 2023 | -34.83 Mn |
| Dec 31, 2023 | -34.83 Mn |